These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4157290)

  • 1. Some pharmacological actions of the beta-adrenolytic agent Ro 3-3528 (6,7-dimethyl-alpha-[(isopropylamino) methyl]-2-benzofuranmethanol Hydrochloride).
    Haefely W; Hürlimann A; Thoenen H
    Angiologica; 1967; 4(3-4):203-15. PubMed ID: 4157290
    [No Abstract]   [Full Text] [Related]  

  • 2. The in vivo examination of the irreversible beta-adrenoceptor antagonist Ro 03-7894 on cardiac rate and contractility.
    Nicholson CD; Broadley KJ; Burden DT; Natoff IL
    Clin Exp Pharmacol Physiol; 1979; 6(6):599-609. PubMed ID: 42499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships in the adrenergic-blocking agents.
    Ghouri MS; Haley TJ
    J Pharm Sci; 1969 May; 58(5):511-38. PubMed ID: 4389589
    [No Abstract]   [Full Text] [Related]  

  • 4. Bamethan A competitive betamimetic drug.
    Marmo E; Saini RK; Caputi AP
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):247-72. PubMed ID: 4152789
    [No Abstract]   [Full Text] [Related]  

  • 5. [Profile of pharmacological actions of NAB 365 (clenbuterol), a novel broncholytic agent with selective activity on adrenergic beta2-receptors (author's transl)].
    Engelhardt G
    Arzneimittelforschung; 1976; 26(7a):1404-20. PubMed ID: 12768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible beta-adrenoceptor blockade of atrial rate and tension responses.
    Nicholson CD; Broadley KJ
    Eur J Pharmacol; 1978 Dec; 52(3-4):259-69. PubMed ID: 32050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bufuralol, a new beta-adrenoceptor blocking agent in a series of benzofuran-2-ethanolamines. Part 2: pharmacology.
    Hamilton TC; Parkes MW
    Arzneimittelforschung; 1977 Jul; 27(7):1410-7. PubMed ID: 20114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological evaluation of new alkylesters of 4-[(2-hydroxy-3-alkylamino)propoxy]phenylcarbamic acids with beta-adrenolytic properties.
    Racanská E; Csöllei J; Svec P
    Pharmazie; 1990 Nov; 45(11):851-3. PubMed ID: 1983125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties of tetrahydropapaveroline.
    Santi R; Ferrari M; Tóth CE; Contessa AR; Fassina G; Bruni A; Luciani S
    J Pharm Pharmacol; 1967 Jan; 19(1):45-51. PubMed ID: 4382174
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of the new beta-adrenolytic compound propyl-3-acetyl-4-[(2-hydroxy-3-isopropylamino) propoxy]carbanylate hydrochloride on isolated heart muscle.
    Knezl V; Magna D; Sotníková R; Drímal J
    Arzneimittelforschung; 1994 Jan; 44(1):7-12. PubMed ID: 7907875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac effects of beta-adrenergic receptor antagonists.
    Ablad B; Carlsson B; Carlsson E; Dahlöf C; Ek L; Hultberg E
    Adv Cardiol; 1974; 12(0):290-302. PubMed ID: 4151859
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitory beta adrenergic receptors in the nictitating membrane of cat.
    Paranjpe BD; Deshpande VR
    Indian J Physiol Pharmacol; 1974; 18(4):366-8. PubMed ID: 4157018
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of an adrenergic beta-receptor blockader, 2-acetyl-7-(2-hydroxy-3-isopropylamino) propoxybenzofuran hydrochloride on the cardiovascular system].
    Takenaka F; Ishihara T; Maruyama Y; Matsumoto S; Inoue H
    Nihon Yakurigaku Zasshi; 1974 May; 70(3):385-97. PubMed ID: 4155394
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist.
    Van de Water A; Janssens W; Van Neuten J; Xhonneux R; De Cree J; Verhaegen H; Reneman RS; Janssen PA
    J Cardiovasc Pharmacol; 1988 May; 11(5):552-63. PubMed ID: 2455841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoreceptor blocking properties of new thienylethanolamine derivatives.
    Darias V; Madroñero R; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1751-6. PubMed ID: 4155632
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamic characterization of bufuralol-HCl and pindolol based on the competitive effects of isoproterenol.
    Magometschnigg D; Bonelli J; Kaik G
    Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):429-32. PubMed ID: 41815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of labetalol on the circulatory system (author's transl)].
    Monma Y; Okuoka Y; Kameda H; Ichihara K; Abiko Y; Tanabe T
    Nihon Yakurigaku Zasshi; 1980 May; 76(4):239-54. PubMed ID: 6108907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alpha- and beta-adrenergic receptor activities of adrenaline on the isolated trachea].
    Otorii T
    Nihon Yakurigaku Zasshi; 1969 Sep; 65(5):551-7. PubMed ID: 4390941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.